🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 5 of 15

  1. US 11110134

    Direct-fed microbials

    Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11104660

    PDE4D inhibitors

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11103504

    Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic treatment

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11096864

    Adapter for a dispensing container in a planetary mixer

    Expires Mon Aug 19 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11091561

    HER-2 binding antibodies

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11090224

    Adaptor for a dispensing container in a planetary mixer

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11078168

    Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11077078

    Compositions and methods for the treatment of cancer

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11077090

    Compounds and compositions and uses thereof

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11066420

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11065214

    Combination therapies with disulfiram

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11053213

    Pharmaceutical compounds

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11046710

    Sulfonamide compounds

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11040984

    Quinazoline compound for EGFR inhibition

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11033516

    Combination therapies with disulfiram

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11033537

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11028061

    Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11028050

    Salts and polymorphs of a PDE4 inhibitor

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11013743

    Cancer treatments using combinations of CDK and ERK inhibitors

    Expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11007183

    Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11008325

    Inhibitors of cancer invasion, attachment, and/or metastasis

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11007184

    Cancer treatments using combinations of type 2 MEK and ERK inhibitors

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11000599

    Peptidic self-assembly for nucleic acid delivery

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 10995087

    Crystal form of URAT1 inhibitor, and preparation method therefor

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10995100

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10995089

    Zaindole derivatives and their use as ERK kinase inhibitors

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10993876

    Pharmaceutical compounding methods and systems

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10988475

    Agonists of the apelin receptor and methods of use thereof

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10988450

    3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10988441

    Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10981915

    Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10981860

    Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10973925

    Methods and compositions for theranostic nanoparticles

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10973758

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10974041

    Neuromodulation device

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10961297

    BTLA fusion protein agonists and uses thereof

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10961205

    1,2,4-oxadiazole derivatives as immunomodulators

    Expires Mon Mar 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10934274

    Quinoline derivatives as TAM RTK inhibitors

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10934299

    Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10927130

    Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10927124

    Compounds and compositions and uses thereof

    Expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10913753

    Thienopyridine carboxamides as ubiquitin-specific protease inhibitors

    Expires Mon Feb 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10906916

    Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10894786

    Substituted pyrazole derivatives as selective CDK12/13 inhibitors

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10894033

    Multicyclic compounds and methods of use thereof

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10889592

    Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10889576

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10881646

    Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.